Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Biotechnology, Pharmaceutical

Headquarters

New York, United States

Employees

1-10

Links

Org chart

Chuck Bramlage

Chief Executive Officer

Collapse

Eugene Prahin

Chief Financial Officer

Tracy Fischer

Senior Vice President – Regulatory Affairs & Quality

Uyen Nguyen

Vice President Of Clinical Research Operations

Brian Cahill

Chief Financial Officer

Teams

This company has no teams yet

Offices

HQ
1 position, 0 job posts

Similar companies

AbbVie

269 followers

Amgen

273 followers

Elanco

26 followers

Bristol-Myers Squibb

250 followers

Gilead Sciences

157 followers

Regeneron

124 followers

AtriCure

4 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies